S1. Ep 13: Medical Economics Pulse, March 21, 2025: Louisiana drops mass vax efforts, it's really not an emergency, pancreatic cancer test

Hello and welcome to "Medical Economics Pulse," a quick-hitting news podcast that keeps busy physicians in the know. We offer concise updates on the most important developments affecting your practice, your bottom line, and the broader health care landscape, delivered to you by our editorial team at Medical Economics.

It’s Friday, March 21, 2025, and here are today’s headlines:

The Louisiana Department of Health has announced it will cease promoting mass vaccination efforts, including media campaigns and community health fairs.This decision, directed by state Surgeon General Dr. Ralph Abraham, emphasizes individual decision-making over government-led initiatives.This policy shift has raised concerns among health care professionals.The Louisiana chapter of the American College of Physicians, along with the Louisiana State Medical Society and the Louisiana Academy of Family Physicians, issued an open letter urging patients to consult their physicians about vaccinations.Furthermore, U.S. Senator Bill Cassidy, M.D., criticized the state's decision, highlighting the importance of vaccine campaigns for public health and convenience.He expressed concern that halting these promotions could lead to decreased vaccination rates and a resurgence of preventable diseases.

Next up, a recent study published in the Journal of the American Medical Association reveals a significant gap between how patients and emergency room physicians assess the urgency of medical conditions.The study analyzed approximately 190 million emergency department visits among adults from 2018 and 2019, comparing patients' reasons for seeking emergency care with physicians' final discharge diagnoses.Findings indicate that agreement on the necessity of emergency care occurred only 38% to 57% of the time.Lead researcher Benjamin Ukert from Texas A&M University highlighted the implications of these findings, noting that nearly 40% of emergency department visits are not medical emergencies.This discrepancy is costly both financially and in terms of hospital resources.

Finally, in promising news for oncology, Immunovia has announced positive results from its VERIFI study, marking the second clinical validation of its next-generation pancreatic cancer diagnostic test.The study met its primary endpoint, with the test successfully identifying 77% of stage I and II pancreatic ductal adenocarcinoma cases.This advancement is crucial, as early detection significantly improves treatment outcomes for one of the deadliest forms of cancer.The results show additional biomarkers supporting the diagnosis of early-stage disease are critical for improving long-term outcomes in pancreatic cancer patients.

And that’s it for today’s Medical Economics Pulse. Be sure to subscribe for new episodes, and read more health business news and expert content at Medical Economics. Be sure to subscribe to our premiere podcast, “Off the Chart, A Business of Medicine Podcast,” which features lively and informative conversations with health care experts, opinion leaders, and practicing physicians about the challenges facing doctors and medical practices.

Thanks for tuning in.